BHE:NYSEBenchmark Electronics, Inc. Analysis
Data as of 2026-05-24 - not real-time
$85.12
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Benchmark Electronics posted a strong first‑quarter with revenue up about 7% year‑over‑year to roughly $677 million and non‑GAAP EPS beating estimates, while raising its full‑year revenue outlook on accelerating demand in AI‑focused computing, semiconductor capital equipment and medical markets. Technical signals show the stock trading above its 20‑day SMA and a bullish trend direction, with the RSI sitting in the mid‑60s, suggesting continued upward momentum despite a bearish MACD crossover and a negative histogram. Volume has been trending lower, which could limit short‑term price thrusts.
Valuation metrics indicate the market is pricing the stock well above fundamentals: the trailing P/E is more than double the industry average and the DCF‑derived fair value sits well under the current price. The dividend yield is modest and the payout ratio near 73% raises questions about long‑term sustainability given cash and debt levels are roughly equal. High beta and 30‑day volatility above 50% point to pronounced price swings, while sector exposure to cyclical electronics components adds medium‑level sector risk. Overall, the stock reflects strong near‑term earnings momentum but appears stretched on price, warranting a cautious stance.
Valuation metrics indicate the market is pricing the stock well above fundamentals: the trailing P/E is more than double the industry average and the DCF‑derived fair value sits well under the current price. The dividend yield is modest and the payout ratio near 73% raises questions about long‑term sustainability given cash and debt levels are roughly equal. High beta and 30‑day volatility above 50% point to pronounced price swings, while sector exposure to cyclical electronics components adds medium‑level sector risk. Overall, the stock reflects strong near‑term earnings momentum but appears stretched on price, warranting a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages indicating bullish momentum
- Bearish MACD crossover suggesting possible near‑term pullback
- Recent earnings beat and raised guidance supporting upside potential
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth outlook driven by AI and medical segments
- Valuation significantly above fair‑value estimates
- Elevated beta and volatility increasing price uncertainty
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Secular demand trends in advanced computing and semiconductor equipment
- Improving cash generation and free cash flow despite high debt
- Potential for valuation re‑rating as earnings compound over time
Key Metrics & Analysis
Financial Health
Revenue Growth7.20%
Profit Margin1.27%
P/E Ratio90.6
ROE3.11%
ROA2.87%
Debt/Equity29.23
P/B Ratio2.8
Op. Cash Flow$139.5M
Free Cash Flow$114.6M
Industry P/E39.5
Technical Analysis
TrendBullish
RSI63.5
Support$66.44
Resistance$87.73
MA 20$82.17
MA 50$68.67
MA 200$51.35
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$56.59
Target Price$78.00
Upside/Downside-8.36%
GradeOvervalued
TypeGrowth
Dividend Yield0.80%
Risk Assessment
Beta1.78
Volatility50.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.